(Updates with final share moves and analyst comments)
Aug 8 (Reuters) - Shares of Myer Holdings (MYR) fell about 7% on Thursday in their worst session in a year, after the Australian department store chain forecast a drop in annual profit owing to less spending by consumers and store closures.
Myer's stock closed 7.1% lower at A$0.780, marking the lowest close in a month and biggest daily drop since August last year. It fell as much as 8.9% earlier in the day.
Over six million shares changed hands during the day, more than four times the 30-day average.
Myer projected a net profit after tax between A$50 million and A$54 million ($32.76 million-$35.38 million) for fiscal 2024, a significant drop from the prior fiscal year's A$71.1 million. Sales were also seen 3% below last year's level.
The bleak outlook reflects "challenging consumer and trading environment, impact of store closures, inflationary cost pressures, and underperformance of three speciality brands", the retailer said in a statement.
Myer estimated the underperformance of its wholly owned fashion brands Sass & Bide, Marcs and David Lawrence accounted for about half of the decline in full-year profit.
"This reporting season will draw a line under a difficult year for Australian retailers in which they navigated soft demand and soaring labour costs," Morningstar analysts wrote in a note.
Morningstar predicted flat sales and earnings for Myer in fiscal 2025.
Myer will report its fiscal 2024 earnings in September.
($1 = 1.5265 Australian dollars)
- Forums
- ASX - By Stock
- PMV
- News: PMV UPDATE 1-Australia's Myer falls 7% as consumer spending woes hurt profit view
PMV
premier investments limited
Add to My Watchlist
1.29%
!
$22.70

News: PMV UPDATE 1-Australia's Myer falls 7% as consumer spending woes hurt profit view
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$22.70 |
Change
0.290(1.29%) |
Mkt cap ! $3.629B |
Open | High | Low | Value | Volume |
$22.62 | $22.92 | $22.51 | $21.70M | 957.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7592 | $22.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$22.70 | 40418 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2800 | 22.500 |
1 | 750 | 22.400 |
1 | 675 | 22.250 |
2 | 4704 | 22.200 |
1 | 225 | 22.100 |
Price($) | Vol. | No. |
---|---|---|
22.850 | 755 | 2 |
22.900 | 1008 | 2 |
23.030 | 157 | 1 |
23.330 | 714 | 1 |
23.500 | 28 | 1 |
Last trade - 16.19pm 21/08/2025 (20 minute delay) ? |
Featured News
PMV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online